News

AIM subscale scores measure affective intensity in bipolar I, II

View on the News

Clinical value of results premature

Dr. Igor I. Galynker
Clinicians could conceivably use AIM subscales for differential diagnosis of bipolar disorder (BD) versus, say, unipolar depression or versus borderline personality disorder, or BD I vs. BD II. Such distinctions could inform treatment selection, specifically whether or not to treat a depressed person with antidepressants and whether or not to use a mood stabilizer to prevent a switch into mania.

Without comparison groups, however, one cannot conclude that the AIM structure is specific to BD; it could be the same across all diagnoses. Thus, before any practical use is possible, further research should optimize and validate the AIM subscales, both in BD and in other diagnoses.

Dr. Igor I. Galynker is director of the Family Center for Bipolar and associate chairman, department of psychiatry and behavioral sciences, Beth Israel Medical Center, New York.


 

FROM THE JOURNAL OF AFFECTIVE DISORDERS

Affect Intensity Measure subscale scores can be used to help understand the complexity of emotions experienced by patients with bipolar disorder I and II, a study of 310 outpatients suggests.

Furthermore, four factors – positive affectivity, "unpeacefulness" (lack of serenity), negative reactivity, and negative intensity – allow clinicians to "explore more subtle components characterizing various aspects of emotional response" among patients with both types of bipolar, Flavie Mathieu, Ph.D., Dr. Bruno Etain, and their colleagues reported (J. Affect. Disord. 2014;157:8-13).

Dr. Flavie Mathieu

The Affect Intensity Measure (AIM) is a 40-item questionnaire designed to measure the extent to which patients experience emotion.

For the study, Dr. Mathieu, Dr. Etain, and their colleagues recruited patients at four university-affiliated psychiatric departments in France. All of the patients included in the study were aged 18 years or older (mean age, 42.4 years). In all, 233 of the patients met the DSM-IV criteria for bipolar disorder I, 65 met the criteria for bipolar II, and 12 for bipolar not otherwise specified, wrote Dr. Mathieu of Université Paris Diderot, Dr. Etain of Hôpital Albert Chenevier, Créteil, France, and their colleagues.

The team developed a French translation of the AIM and got it "backtranslated" by an independent translator. The patients were asked to describe their affect during euthymic periods rather than during either manic or depressive episodes. Euthymic states were confirmed based on the patients’ scores on the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Mania Rating Scale.

No statistically significant association was found between the patients’ total AIM scores and the clinical characteristics of bipolar disorder. However, when the investigators looked at the four factors, they found significant associations between the AIM subscale scores and bipolar disorder characteristics. For example, the unpeacefulness subscale score was associated with the onset of psychotic symptoms (P = .0006) and substance misuse (P = .008). The negative intensity subscale score was associated with social phobia (P = .0005).

The investigators cited several limitations. For example, they found no correlation between the patients’ total AIM scores and MADRS scores, which suggests that "AIM total score is not necessarily influenced by depression."

Despite these limitations, the investigators said their findings "suggest that assessment of affective intensity using this self-report scale may be useful in clinical settings but also as a means of further characterizing [bipolar disorder] phenotypes in future research."

The research was funded by INSERM, Assistance Publique des Hôpitaux de Paris, Agence National pour la Recherche, and the Fondation FondaMental. The authors reported no financial conflicts.

ghenderson@frontlinemedcom.com

Recommended Reading

Depression, not cognitive deficits, improves with sleep loss in bipolar I
MDedge Internal Medicine
Emotion regulation strategies distinguish borderline, bipolar II
MDedge Internal Medicine
Brain tractography finds white matter abnormalities in bipolar I patients
MDedge Internal Medicine
Health care reform may cut behavioral admissions
MDedge Internal Medicine
Symptom summary worksheets alert patients to signs of mania, depression
MDedge Internal Medicine
Overgeneral autobiographical memory is a trait of bipolar I
MDedge Internal Medicine
Axis I ailments common in hypersexual disorder
MDedge Internal Medicine
High-yield techniques in brief CBT sessions can promote adherence
MDedge Internal Medicine
Pharmacist discovery spurs recall of extended-release venlafaxine
MDedge Internal Medicine
Group issues recommendations for genetic susceptibility testing for carbamazepine skin reactions
MDedge Internal Medicine